{"data": [{"news_url": "https://www.fool.com/investing/2020/06/03/report-trump-administration-picks-5-most-likely-co.aspx", "image_url": "https://cdn.snapi.dev/images/v1/6/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5771522fcoronavirus-vaccine-bottlesjpgw700opresize.jpg", "title": "Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support", "text": "The White House reportedly plans to route extra federal funds and other assistance to the companies developing those potential SARS-CoV-2 vaccines.", "source_name": "The Motley Fool", "date": "Wed, 03 Jun 2020 17:03:00 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["AZN", "BNTX", "JNJ", "MRK", "MRNA", "PFE"]}, {"news_url": "https://investorplace.com/2020/06/moderna-may-not-be-what-speculators-thought/", "image_url": "https://cdn.snapi.dev/images/v1/k/d/biotech39.jpg", "title": "Moderna May Not Be What Speculators Thought", "text": "With demand sky-high for a coronavirus vaccine, it was only natural that MRNA stock jumped higher on Moderna\u2019s encouraging early stage clinical trial results. However, its questionable practices are now coming into closer view.", "source_name": "InvestorPlace", "date": "Wed, 03 Jun 2020 11:13:16 -0400", "topics": [], "sentiment": "Negative", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/06/03/why-moderna-shares-rose-337-in-may.aspx", "image_url": "https://cdn.snapi.dev/images/v1/a/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5770272fgettyimages-1205913548jpgw700opresize.jpg", "title": "Why Moderna Shares Rose 33.7% in May", "text": "Positive data from a coronavirus vaccine trial drove share gains.", "source_name": "The Motley Fool", "date": "Wed, 03 Jun 2020 09:57:00 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/06/03/is-a-covid-19-vaccine-supply-glut-on-the-way.aspx", "image_url": "https://cdn.snapi.dev/images/v1/9/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5766192fvaccine-bottlesjpgw700opresize.jpg", "title": "Is a COVID-19 Vaccine Supply Glut on the Way?", "text": "Dozens of drugmakers are developing COVID-19 vaccines and gearing up to produce billions of doses each year.", "source_name": "The Motley Fool", "date": "Wed, 03 Jun 2020 07:02:00 -0400", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["AZN", "GSK", "INO", "JNJ", "MRNA", "NVAX", "PFE"]}, {"news_url": "https://www.forbes.com/sites/greatspeculations/2020/06/03/what-to-expect-as-modernas-covid-19-vaccine-commences-phase-2-trials/", "image_url": "https://cdn.snapi.dev/images/v1/m/8/what-to-expect-as-modernas-covid-19-vaccine-commences-phase-2-trials.jpg", "title": "What To Expect As Moderna\u2019s Covid-19 Vaccine Commences Phase 2 Trials", "text": "Moderna said that it commenced stage 2 trials for its new Coronavirus vaccine candidate mRNA-1273 last week. The company intends to enroll a total of 600 participants in the study, up from 45 participants in the phase 1 study.", "source_name": "Forbes", "date": "Wed, 03 Jun 2020 06:14:54 -0400", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}]}